Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c
| Status: | Completed |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/19/2018 |
| Start Date: | March 3, 2017 |
| End Date: | February 28, 2018 |
The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes -
Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized
controlled trial that aims to evaluate the impact of the Digital Self-Management Program on
A1c levels for individuals with uncontrolled Type 2 diabetes.
Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized
controlled trial that aims to evaluate the impact of the Digital Self-Management Program on
A1c levels for individuals with uncontrolled Type 2 diabetes.
Inclusion Criteria:
- Humana Medicare Advantage member
- Type 2 diabetes diagnosis
- HbA1c levels ≥ 8.0% verified by lab test
Exclusion Criteria:
- Has any of the following conditions: cancer, chronic heart failure, chronic
obstructive pulmonary disease, respiratory failure, chronic kidney disease, end stage
renal disease, peripheral vascular disease
- Not fluent in English
- Humana membership is part of a Full or Global risk arrangement
- Enrolled in Humana at Home Care Management
We found this trial at
1
site
Click here to add this to my saved trials
